FIELD: medicine.
SUBSTANCE: invention can be used in otorhinolaryngology. Invention is a therapeutic elixir for irrigation of the mucous membrane of the maxillary sinus with plastic oroanthral fistula, including the 0.05 % solution of chlorhexidine bigluconate in the amount of 50 wt. %, characterized in that it additionally contains "Polysorb MP" in the amount of 30 wt. %, 0.5 % hyaluronic acid in the amount of 10 wt. % and lidocaine hydrochloride in the amount of 10 wt. %.
EFFECT: therapeutic elixir has detoxification and antioxidant properties, it has a pronounced hyperosmolar activity, as a result of which it suppresses wound and perifocal inflammation, absorbs purulent exudate and mucus, provides anesthetic effect, does not damage granulation and viable epithelial scyphoid cells of the maxillary sinus mucosa, it does not inhibit marginal epithelization of the oroantral fistula after surgery for its surgical removal.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ADHESIVE POLYMERIC SOLUBLE FILM FOR DRUG DEPOSITION ON SURFACE OF NASAL AND SUPRA-LATERAL SINUS MUCOSA | 2016 |
|
RU2634259C1 |
METHOD OF TREATING MAXILLARY SINUSITIS | 2008 |
|
RU2373873C2 |
METHOD FOR KNEE CAP LATERAL FIXATION | 2010 |
|
RU2441609C1 |
UNIVERSAL LIQUID MARKER FOR DETERMINATION OF EXCRETORY AND SUCTIONAL ABILITY OF NASAL MUCOSA AND MAXILLARY SINUS | 2016 |
|
RU2632717C1 |
METHOD FOR TREATING THE CASES OF CHRONIC ODONTOGENIC PERFORATED MAXILLARY SINUSITIS | 1992 |
|
RU2035894C1 |
METHOD OF TREATING ODONTOGENIC PERFORATIVE MAXILLARY SINUSITIS | 2009 |
|
RU2408309C1 |
OSTEOPLASTIC COMPOSITION FOR SUBANTRAL AUGMENTATION | 2019 |
|
RU2729651C1 |
LIQUID MARKER FOR DETERMINATION OF RESPIRATORY EPITHELIAL CLEARANCE SPEED OF NASAL MUCOSA AND MAXILLARY SINUS | 2016 |
|
RU2640174C2 |
METHOD FOR OPTIMIZING REPARATIVE OSTEOGENESIS | 2020 |
|
RU2738406C1 |
METHOD OF SUBANTRAL BONE AUGMENTATION FOR DENTAL IMPLANTATION IN UPPER RIDGE ATROPHY | 2011 |
|
RU2469675C1 |
Authors
Dates
2019-02-14—Published
2016-04-25—Filed